{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:44:17Z","timestamp":1793893457947,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Central lymph node status in papillary thyroid microcarcinoma (PTMC) plays an important role in treatment decision-making clinically, however, it is not easy to predict central lymph node metastasis (CLNM). The present work focused on finding the more rational alternative for evaluating central lymph node status while identifying influencing factors to construct a model to predict CLNM incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we retrospectively analyzed the typical sonographic and clinicopathologic features of 546 PTMC patients who underwent surgery, among which, the data of 382 patients were recruited in the training cohort and that of 164 patients in the validation cohort. Based on the outcome of the training cohort, significant influencing factors were further identified through univariate analysis and were considered as independent variables in multivariable logistic regression analysis and incorporated in and presented with a nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, six independent predictors, including the age, sex, tumor size, multifocality, capsular invasion, Hashimotos thyroiditis were entered into the nomogram. Both internal validation and external validation revealed the favorable discrimination of our as-constructed nomogram. Calibration curves exhibited high consistency. As suggested by decision-curve analyses, the as-constructed nomogram might be applied in clinic. Besides, the model also distinguished patients according to risk stratification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The novel nomogram containing remarkable influencing factors for CLNM cases was established in the present work. The nomogram can assist clinicians in clinical decision-making.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-09655-5","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T22:02:26Z","timestamp":1654207346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Qian-wen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-lin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"issue":"5","key":"9655_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/thy.2019.0420","volume":"30","author":"Y Yoshida","year":"2020","unstructured":"Yoshida Y, Horiuchi K, Okamoto T. Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery. Thyroid. 2020;30(5):681\u20137.","journal-title":"Thyroid"},{"issue":"6","key":"9655_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000503064","volume":"8","author":"MJ Jeon","year":"2019","unstructured":"Jeon MJ, Kim WG, Chung K-W, Baek JH, Kim WB, Shong YK. Active surveillance of papillary thyroid microcarcinoma: where do we stand? Eur Thyroid J. 2019;8(6):298\u2013306.","journal-title":"Eur Thyroid J"},{"issue":"11","key":"9655_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41574-018-0080-7","volume":"14","author":"TS Wang","year":"2018","unstructured":"Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer\u2014recent advances and future directions. Nat Rev Endocrinol. 2018;14(11):670\u201383.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"9655_CR4","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/EJE-21-0256","volume":"185","author":"E Molinaro","year":"2021","unstructured":"Molinaro E, Campopiano MC, Elisei R. Management of endocrine disease: papillary thyroid microcarcinoma: toward an active surveillance strategy. Eur J Endocrinol. 2021;185(1):R23\u2013r34.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9655_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cncr.30360","volume":"123","author":"BR Haugen","year":"2017","unstructured":"Haugen BR. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123(3):372\u201381.","journal-title":"Cancer"},{"issue":"11","key":"9655_CR6","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"5","key":"9655_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.21037\/gs.2017.09.08","volume":"7","author":"TM Ullmann","year":"2018","unstructured":"Ullmann TM, Gray KD, Moore MD, Zarnegar R, Fahey TJ III. Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers. Gland Surg. 2018;7(5):473.","journal-title":"Gland Surg"},{"issue":"20","key":"9655_CR8","first-page":"30062","volume":"S1808\u20138694","author":"L Jiwang","year":"2020","unstructured":"Jiwang L, Yahong L, Kai L, Bo H, Yuejiao Z, Haotian W, et al. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study. Brazilian J Otorhinolaryngol. 2020;S1808\u20138694(20):30062\u20138.","journal-title":"Brazilian J Otorhinolaryngol"},{"issue":"1","key":"9655_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"key":"9655_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"P Perros","year":"2014","unstructured":"Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81:1\u2013122.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"9655_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.20892\/j.issn.2095-3941.2017.0051","volume":"14","author":"M Gao","year":"2017","unstructured":"Gao M, Ge M, Ji Q, Cheng R, Lu H, Guan H, et al. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med. 2017;14(3):203\u201311.","journal-title":"Cancer Biol Med"},{"issue":"2","key":"9655_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/thy.2020.0330","volume":"31","author":"I Sugitani","year":"2021","unstructured":"Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid. 2021;31(2):183\u201392.","journal-title":"Thyroid"},{"issue":"3","key":"9655_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000354537","volume":"2","author":"L Leenhardt","year":"2013","unstructured":"Leenhardt L, Erdogan M, Hegedus L, Mandel S, Paschke R, Rago T, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J. 2013;2(3):147\u201359.","journal-title":"Eur Thyroid J"},{"issue":"1","key":"9655_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jso.21164","volume":"99","author":"JL Roh","year":"2009","unstructured":"Roh JL, Park JY, Kim JM, Song CJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol. 2009;99(1):28\u201331.","journal-title":"J Surg Oncol"},{"issue":"3","key":"9655_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/lary.21227","volume":"121","author":"HS Hwang","year":"2011","unstructured":"Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121(3):487\u201391.","journal-title":"Laryngoscope"},{"issue":"2","key":"9655_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejso.2012.07.119","volume":"39","author":"D Lee","year":"2013","unstructured":"Lee D, Ji YB, Sung E, Park J, Lee Y, Park DW, et al. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur J Surg Oncol (EJSO). 2013;39(2):191\u20136.","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"4","key":"9655_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/thy.2007.0269","volume":"18","author":"E Kim","year":"2008","unstructured":"Kim E, Park JS, Son K-R, Kim J-H, Jeon SJ, Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008;18(4):411\u20138.","journal-title":"Thyroid"},{"key":"9655_CR18","doi-asserted-by":"publisher","first-page":"109103","DOI":"10.1016\/j.ejrad.2020.109103","volume":"129","author":"Z Xing","year":"2020","unstructured":"Xing Z, Qiu Y, Yang Q, Yu Y, Liu J, Fei Y, et al. Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol. 2020;129:109103.","journal-title":"Eur J Radiol"},{"issue":"11","key":"9655_CR19","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.7863\/ultra.15.10012","volume":"35","author":"W-H Wang","year":"2016","unstructured":"Wang W-H, Xu S-Y, Zhan W-W. Clinicopathologic factors and thyroid nodule sonographic features for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study of 1204 patients. J Ultrasound Med. 2016;35(11):2475\u201381.","journal-title":"J Ultrasound Med"},{"issue":"6","key":"9655_CR20","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1007\/s13277-015-4535-3","volume":"37","author":"Y Gao","year":"2016","unstructured":"Gao Y, Qu N, Zhang L, Chen JY, Ji QH. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma. Tumor Biol. 2016;37(6):7453\u20139.","journal-title":"Tumor Biol"},{"issue":"6","key":"9655_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.anorl.2018.07.010","volume":"136","author":"H Liu","year":"2019","unstructured":"Liu H, Li Y, Mao Y. Local lymph node recurrence after central neck dissection in papillary thyroid cancers: a meta analysis. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(6):481\u20137.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"9655_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bjorl.2018.05.004","volume":"85","author":"H Su","year":"2019","unstructured":"Su H, Li Y. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis\u2606,\u2606\u2606. Braz J Otorhinolaryngol. 2019;85:237\u201343.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"9","key":"9655_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/jjco\/hyt087","volume":"43","author":"W Zhu","year":"2013","unstructured":"Zhu W, Zhong M, Ai Z. Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma. Jpn J Clin Oncol. 2013;43(9):883\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"9655_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/thy.2012.0011","volume":"22","author":"D Giordano","year":"2012","unstructured":"Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid. 2012;22(9):911\u20137.","journal-title":"Thyroid"},{"issue":"5","key":"9655_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.amjoto.2017.06.004","volume":"38","author":"D Giordano","year":"2017","unstructured":"Giordano D, Frasoldati A, Gabrielli E, Pernice C, Zini M, Castellucci A, et al. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma. Am J Otolaryngol. 2017;38(5):576\u201381.","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"9655_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1245\/s10434-009-0384-x","volume":"16","author":"JY Kwak","year":"2009","unstructured":"Kwak JY, Kim E-K, Kim MJ, Son EJ, Chung WY, Park CS, et al. Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann Surg Oncol. 2009;16(5):1348\u201355.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9655_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00268-005-0113-y","volume":"30","author":"Y Ito","year":"2006","unstructured":"Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30(1):91\u20139.","journal-title":"World J Surg"},{"issue":"3","key":"9655_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.SLA.0000055273.58908.19","volume":"237","author":"N Wada","year":"2003","unstructured":"Wada N, Duh Q-Y, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399.","journal-title":"Ann Surg"},{"issue":"6","key":"9655_CR29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.surg.2008.08.035","volume":"144","author":"ID Hay","year":"2008","unstructured":"Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144(6):980\u20138.","journal-title":"Surgery"},{"issue":"1","key":"9655_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cncr.11442","volume":"98","author":"SM Chow","year":"2003","unstructured":"Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid\u2014prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98(1):31\u201340.","journal-title":"Cancer"},{"issue":"17","key":"9655_CR31","first-page":"3801","volume":"21","author":"M Li","year":"2017","unstructured":"Li M, Zhu XY, Lv J, Lu K, Shen MP, Xu ZL, et al. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections. Eur Rev Med Pharmacol Sci. 2017;21(17):3801\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"9655_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40618-017-0759-y","volume":"41","author":"CY Gui","year":"2018","unstructured":"Gui CY, Qiu SL, Peng ZH, Wang M. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study. J Endocrinol Investig. 2018;41(4):403\u20139.","journal-title":"J Endocrinol Investig"},{"issue":"12","key":"9655_CR33","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s40618-020-01326-1","volume":"43","author":"JW Feng","year":"2020","unstructured":"Feng JW, Ye J, Wu WX, Qu Z, Qin AC, Jiang Y. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence. J Endocrinol Investig. 2020;43(12):1807\u201317.","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"9655_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00405-020-05787-1","volume":"277","author":"C Zhang","year":"2020","unstructured":"Zhang C, Li BJ, Liu Z, Wang LL, Cheng W. Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma. Eur Arch Otorhinolaryngol. 2020;277(4):1191\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"9655_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.amjsurg.2019.11.032","volume":"220","author":"L Sheng","year":"2020","unstructured":"Sheng L, Shi J, Han B, Lv B, Li L, Chen B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma. Am J Surg. 2020;220(2):334\u201340.","journal-title":"Am J Surg"},{"key":"9655_CR36","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.2147\/CMAR.S248374","volume":"12","author":"G-M Fu","year":"2020","unstructured":"Fu G-M, Wang Z-H, Chen Y-B, Li C-H, Zhang Y-J, Li X-J, et al. Analysis of risk factors for lymph node metastases in elderly patients with papillary thyroid micro-carcinoma. Cancer Manag Res. 2020;12:7143.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"9655_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MNM.0000000000001119","volume":"41","author":"G Shen","year":"2020","unstructured":"Shen G, Ma H, Huang R, Kuang A. Predicting large-volume lymph node metastasis in the clinically node-negative papillary thyroid microcarcinoma: a retrospective study. Nucl Med Commun. 2020;41(1):5\u201310.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"9655_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"J Ding","year":"2020","unstructured":"Ding J, Wu W, Fang J, Zhao J, Jiang L. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma. Sci Rep. 2020;10(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"2","key":"9655_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00268-010-0886-5","volume":"35","author":"KJ Lee","year":"2011","unstructured":"Lee KJ, Cho YJ, Kim SJ, Lee SC, Kim JG, Ahn CJ, et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg. 2011;35(2):318\u201323.","journal-title":"World J Surg"},{"key":"9655_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2147\/CMAR.S154135","volume":"10","author":"Y Gong","year":"2018","unstructured":"Gong Y, Li G, Lei J, You J, Jiang K, Li Z, et al. A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases. Cancer Manag Res. 2018;10:899.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"9655_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.rceng.2019.12.012","volume":"221","author":"JR Pardo","year":"2021","unstructured":"Pardo JR, Zambudio AR, Gonz\u00e1lez JR, Quiles MP, Gim\u00e9nez VS, Ram\u00edrez MO, et al. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment? Revista Cl\u00ednica Espa\u00f1ola (English Edition). 2021;221(3):131\u20138.","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"issue":"4","key":"9655_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ciresp.2019.10.003","volume":"98","author":"JR Pardo","year":"2020","unstructured":"Pardo JR, R\u00edos A, Rodr\u00edguez JM, Paredes M, Soriano V, Oviedo MI, et al. Factores de riesgo de met\u00e1stasis ganglionares en el microcarcinoma papilar de tiroides. Cirug\u00eda Espa\u00f1ola. 2020;98(4):219\u201325.","journal-title":"Cirug\u00eda Espa\u00f1ola"},{"issue":"6","key":"9655_CR43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.bulcan.2017.03.005","volume":"104","author":"J Yuan","year":"2017","unstructured":"Yuan J, Li J, Chen X, Lin X, Du J, Zhao G, et al. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma. Bull Cancer. 2017;104(6):516\u201323.","journal-title":"Bull Cancer"},{"issue":"5","key":"9655_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.14639\/0392-100X-1709","volume":"37","author":"J Liang","year":"2017","unstructured":"Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, et al. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients. Acta Otorhinolaryngol Ital. 2017;37(5):393.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"9","key":"9655_CR45","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hed.21594","volume":"33","author":"SS Kim","year":"2011","unstructured":"Kim SS, Lee BJ, Lee JC, Kim SJ, Jeon YK, Kim MR, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis. Head Neck. 2011;33(9):1272\u20137.","journal-title":"Head Neck"},{"issue":"8","key":"9655_CR46","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","volume":"27","author":"JS Jeong","year":"2012","unstructured":"Jeong JS, Kim HK, Lee C-R, Park S, Park JH, Kang S-W, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci. 2012;27(8):883\u20139.","journal-title":"J Korean Med Sci"},{"key":"9655_CR47","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.2147\/CMAR.S199921","volume":"11","author":"BD Chen","year":"2019","unstructured":"Chen BD, Zhang Z, Wang KK, Shang MY, Zhao SS, Ding WB, et al. A multivariable model of BRAF(V600E) and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019;11:7211\u20137.","journal-title":"Cancer Manag Res"},{"key":"9655_CR48","doi-asserted-by":"publisher","first-page":"742328","DOI":"10.3389\/fsurg.2021.742328","volume":"8","author":"L Zhang","year":"2021","unstructured":"Zhang L, Ling Y, Zhao Y, Li K, Zhao J, Kang H. A nomogram based on Clinicopathological and ultrasound imaging characteristics for predicting cervical lymph node metastasis in cN0 unilateral papillary thyroid microcarcinoma. Front Surg. 2021;8:742328.","journal-title":"Front Surg"},{"issue":"3","key":"9655_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40618-021-01675-5","volume":"45","author":"X Wei","year":"2022","unstructured":"Wei X, Min Y, Feng Y, He D, Zeng X, Huang Y, et al. Development and validation of an individualized nomogram for predicting the high-volume (>\u0411\u2500\u25345) central lymph node metastasis in papillary thyroid microcarcinoma. J Endocrinol Investig. 2022;45(3):507\u201315.","journal-title":"J Endocrinol Investig"}],"updated-by":[{"DOI":"10.1186\/s12885-022-09768-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09655-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T21:03:27Z","timestamp":1668373407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9655"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09655-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-022-09768-x","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"25 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-022-09768-x","URL":"https:\/\/doi.org\/10.1186\/s12885-022-09768-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedure conformed to the ethical guidelines of the Declaration of Helsinki, and the approval for the study was obtained from the Medical Ethics Committee of Hebei General Hospital. Informed consent was waived by the Institutional Ethics Committee of Hebei General Hospital because of the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"606"}}